Arguably considered a type of regenerative medicine, peptide therapy is an effective treatment for a variety of conditions and symptoms related to insufficient peptide levels
Discover Our Peptide Portfolio In 2023, the FDA reviewed several peptides nominated for compounding and placed many on the 503A Category 2 list.[3] Then in 2024, the agency cited limited clinical safety data, along with concerns about immunogenicity (how the immune system might respond) and dosing variability.[4] It was a precautionary decision, and precaution is an important part of regulatory oversight
Early research indicates significant promise for its dual role in appetite regulation and metabolic enhancement, particularly for patients unresponsive to GLP-1 monotherapy
Glutathione is a key antioxidant in the brain, as it is the first line of defence in protecting against reactive oxygen species, which are cellular by-products that can lead to cellular damage, oxidative stress, and DNA damage
Gonzalez-De la Rosa, ., Safety and Tolerability of Topical Ophthalmic Triamcinolone Acetonide-Loaded Liposomes Formulation and Evaluation of Its Biologic Activity in Patients with Diabetic Macular Edema, Pharmaceutics
